What is Kyverna Therapeutics, Inc.'s financing cash flow?

Kyverna Therapeutics, Inc. (KYTX) reported financing cash flow of -$101K in Q1 2026.

How has Kyverna Therapeutics, Inc.'s financing cash flow changed year-over-year?

Kyverna Therapeutics, Inc.'s financing cash flow increased by 75.6% year-over-year, from -$414K to -$101K.

What does financing cash flow mean?

Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.

Kyverna Therapeutics, Inc. KYTX Financing Cash Flow

Financing Cash Flow at other companies

Bristol-Myers SquibbBMY

-$1.56B-57.1%

Gilead SciencesGILD

-$4.24B-23.7%

Climb Bio, Inc.CLYM

$5K—

Artiva Biotherapeutics, Inc.ARTV

-$112K-147%

Iovance Biotherapeutics, Inc.IOVA

$94.34M-34.2%

Viridian Therapeutics, Inc.VRDN

$6.36M-31.0%

Other financials

Income statement

See full

Operating income-$41.4M+12.7%

Net income-$39.7M+11.0%

EPS (diluted)-$0.66+35.9%

Balance sheet

See full

Cash & equivalents$32.2M-43.4%

Total debt$9.2M+32.1%

Total equity$195.6M-12.7%

Total assets$257.0M-1.4%

Cash flow

See full

Operating cash flow-$41.6M+7.4%

CapEx$2.0K-98.0%

Free cash flow-$33.5M+10.8%

Valuation

See full

Market cap$498.52M+276%

Enterprise value$475.49M+475%

Returns & leverage

See full

Return on equity-74.5%+74.4pp

Debt / equity0×0.0×

Current ratio8.1×+0.7×

Where this comes from

Reported directly by Kyverna Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.

The official record: Kyverna Therapeutics, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kyverna Therapeutics, Inc.'s financing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Kyverna Therapeutics, Inc.'s financing cash flow?: Kyverna Therapeutics, Inc. (KYTX) reported financing cash flow of -$101K in Q1 2026.
How has Kyverna Therapeutics, Inc.'s financing cash flow changed year-over-year?: Kyverna Therapeutics, Inc.'s financing cash flow increased by 75.6% year-over-year, from -$414K to -$101K.
What does financing cash flow mean?: Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.